Evidence map›Paper›PMID 24445428›Full record

ArticleJAMA neurology2014

Variant Creutzfeldt-Jakob disease with extremely low lymphoreticular deposition of prion protein.

Simon Mead, Jonathan D F Wadsworth, Marie-Claire Porter, Jacqueline M Linehan, Wojciech Pietkiewicz, Graham S Jackson, Sebastian Brandner, John Collinge

Open access · greenAbstract readCase Reports
In one paragraph

Article in JAMA neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Non-human primates in prion diseases.Cell and tissue research · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Simon MeadNational Prion Clinic, National Hospital for Neurology and Neurosurgery, Queen Square, London, England2Medical Research Council Prion Unit, Department of Neurodegenerative Disease, University College London Institute of Neurology, Queen Square, London, En.
Jonathan D F WadsworthMedical Research Council Prion Unit, Department of Neurodegenerative Disease, University College London Institute of Neurology, Queen Square, London, England.
Marie-Claire PorterNational Prion Clinic, National Hospital for Neurology and Neurosurgery, Queen Square, London, England.
Jacqueline M LinehanMedical Research Council Prion Unit, Department of Neurodegenerative Disease, University College London Institute of Neurology, Queen Square, London, England.
Wojciech PietkiewiczThe Walton Centre NHS Foundation Trust, Fazakerley, Liverpool, England.
Graham S JacksonMedical Research Council Prion Unit, Department of Neurodegenerative Disease, University College London Institute of Neurology, Queen Square, London, England.
Sebastian BrandnerDivision of Neuropathology, Department of Neurodegenerative Disease, University College London Institute of Neurology, Queen Square, London, England.
John CollingeNational Prion Clinic, National Hospital for Neurology and Neurosurgery, Queen Square, London, England2Medical Research Council Prion Unit, Department of Neurodegenerative Disease, University College London Institute of Neurology, Queen Square, London, En.
MRC Prion Unit · GBNational Hospital for Neurology and Neurosurgery · GBUniversity College London · GBMedical Research Council · GBUniversity of Liverpool · GB

Funding

Department of HealthMedical Research Council MC_U123160651Medical Research Council MC_U123160655Medical Research Council MC_U123160657Medical Research Council MC_U123170362
6 · The paper itself

Abstract

importanceHuman transmission of bovine spongiform encephalopathy causes the fatal neurodegenerative condition variant Creutzfeldt-Jakob disease (vCJD) and, based on recent human prevalence studies, significant subclinical prion infection of the UK population. To date, all clinical cases have been fatal, totaling 228 mostly young adults residing in the United Kingdom. OBSERVATIONS: Here we describe the investigation and case history of a patient recently diagnosed as having vCJD in the United Kingdom. Although his presentation, imaging findings, cerebrospinal fluid investigation results, and clinical progression were typical of other cases, tonsillar biopsy and subsequent examination of multiple tissues at autopsy showed minimal deposition of disease-associated prion protein in peripheral lymphoreticular tissue. The result of a blood test for vCJD, the Direct Detection Assay for vCJD, was negative. CONCLUSIONS AND RELEVANCE: These findings suggest that some patients with vCJD have very low peripheral prion colonization and therefore may not have detectable prion deposition in diagnostic tonsillar biopsy or markers of prion infection in blood. These results have implications for accurate interpretation of diagnostic tests and prevalence studies based on lymphoreticular tissue or blood.

Indexed as

AdultCreutzfeldt-Jakob SyndromeFatal OutcomeHumansLymphoid TissueMalePalatine TonsilPrionsUnited KingdomPrions

Identifiers

PMID24445428
PMCPMC4158717
OpenAlexW1985494354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.